PPM1D expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.451200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.539400E-01
Normal-vs-Stage2
2.732200E-01
Normal-vs-Stage3
4.136300E-02
Normal-vs-Stage4
5.272800E-01
Stage1-vs-Stage2
6.034400E-02
Stage1-vs-Stage3
1.025960E-01
Stage1-vs-Stage4
5.477200E-01
Stage2-vs-Stage3
2.445200E-01
Stage2-vs-Stage4
5.193000E-01
Stage3-vs-Stage4
9.778100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.282600E-01
Normal-vs-AfricanAmerican
8.755000E-01
Normal-vs-Asian
2.547000E-01
Caucasian-vs-AfricanAmerican
2.516600E-01
Caucasian-vs-Asian
5.180400E-01
AfricanAmerican-vs-Asian
2.052200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.857000E-01
Normal-vs-Female
4.361400E-01
Male-vs-Female
2.423800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.939800E-01
Normal-vs-Age(41-60Yrs)
6.382000E-01
Normal-vs-Age(61-80Yrs)
2.590400E-01
Normal-vs-Age(81-100Yrs)
1.262370E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.592200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.269400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.862160E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.045720E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.292300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.071600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.910200E-02
Normal-vs-Daily Drinker
3.085800E-02
Normal-vs-Weekly Drinker
2.129600E-01
Normal-vs-Occasional Drinker
5.250200E-01
Normal-vs-Social Drinker
7.246800E-01
Non Drinker-vs-Daily Drinker
5.229000E-01
Non Drinker-vs-Weekly Drinker
6.671400E-01
Non Drinker-vs-Occasional Drinker
3.364200E-01
Non Drinker-vs-Social Drinker
4.426200E-02
Daily Drinker-vs-Weekly Drinker
3.595200E-01
Daily Drinker-vs-Occasional Drinker
1.835410E-01
Daily Drinker-vs-Social Drinker
1.952120E-02
Weekly Drinker-vs-Occasional Drinker
6.010200E-01
Weekly Drinker-vs-Social Drinker
2.186800E-01
Occasional Drinker-vs-Social Drinker
5.438000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.728400E-02
Normal-vs-Grade 2
7.575700E-02
Normal-vs-Grade 3
8.471500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.080200E-01
Grade 1-vs-Grade 3
1.766370E-01
Grade 1-vs-Grade 4
9.728400E-02
Grade 2-vs-Grade 3
7.306600E-01
Grade 2-vs-Grade 4
7.575700E-02
Grade 3-vs-Grade 4
8.471500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.734210E-01
Normal-vs-NonDiabetic
2.618600E-01
Diabetic-vs-NonDiabetic
5.798800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.599570E-01
Normal-vs-NoPancreatitis
2.624000E-01
Pancreatitis-vs-NoPancreatitis
6.871600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.467600E-01
Normal-vs-N1
2.825000E-01
N0-vs-N1
8.617600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.630500E-02
Normal-vs-TP53-NonMutant
8.603400E-01
TP53-Mutant-vs-TP53-NonMutant
1.88596999999291E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
